Wealthcreatures.com
https://wealthcreatures.com/2020/06/15/magma-fincorp-dark-horse-for-longterm-can-it-again-cross-its-all-time-high-194/ Just Like Magma fincorp Takeover by poonawala Fincorp gone made from 18 to 300+ in just 3yrs Same way Asian Tiles can be next Poonawala…
ASIAN TILES
Fresh 52wk High
8% 💥 💚
47 To 83.95 ✅
83.95
78% Upmove in 6 months
Next few stocks which can move like this already Given....Concentrate on that
Fresh 52wk High
8% 💥 💚
47 To 83.95 ✅
83.95
78% Upmove in 6 months
Next few stocks which can move like this already Given....Concentrate on that
Wealthcreatures.com
Diwali pick before Diwali Vikram Thermo Cmp - 56 Accmulation zone - 48 To 56 Support@ 45/41 Test Levels- 75/85/100/120/150+ Demerger already announced Value unlocking coming S/L - 37.25 on cbsl or As Per Risk
Last Diwali pick
Vikram Thermo
Last Diwali pick
Aft Reco went down till 45 & nvr moved for 4 to 5 months and than upmove came
50 To 133
Cmp - 113
Still huge steam Left
Vikram Thermo
Last Diwali pick
Aft Reco went down till 45 & nvr moved for 4 to 5 months and than upmove came
50 To 133
Cmp - 113
Still huge steam Left
Wealthcreatures.com
SPECIAL DIWALI BONUS PICK 🪔 SAKAR HEALTHCARE 🪔 CMP - 153.70 ACCMULATION ZONE - 140 To 154 Test Levels # 225/300/333/500/600++ TF - 6/12/18/24/36 Months S/L - 99 on cbsl OR As Per Risk
SAKAR HEALTHCARE
2021 Diwali pick
Went down till 125 - 130 zone
ATH - 398
Now around - 335
Expecting 4 digits ➕️ in next 12 Qtrs
2021 Diwali pick
Went down till 125 - 130 zone
ATH - 398
Now around - 335
Expecting 4 digits ➕️ in next 12 Qtrs
Wealthcreatures.com
AURIONPRO Steady Numbers Q2FY24 Continues to grow at 30-35% maintaining the margins ( As Management had Guided Earlier) Revenue at 211cr vs 154cr⬆️37% EBITDA at 46cr vs 35cr⬆️32% OPM at 21.82% for q2 PBT at 40.5cr vs 29cr Q1 at 38cr PAT at 34cr vs 25cr…
AURIONPRO
Fresh 52wk & ATH TODAY
1633
Should do Well in coming Days
Already 410 To 1633 done till now
Still Longway to Go
Fresh 52wk & ATH TODAY
1633
Should do Well in coming Days
Already 410 To 1633 done till now
Still Longway to Go
Wealthcreatures.com
1.Persistent Systems Cmp - 6085 Accmumate - 5800 6085 zone Already given earlier also SL 5600 Test Levels - 10000/11000 if can wait for 18 months Short tem T 6800 2. REPL Cmp - 215 Accmulate bwt - 201 - 215 zone SL 184 Test levels - 280+…
SPANDANA SPOORTHY
PAT at Rs.116 cr vs Rs.50 cr,
up 2.3 Times YoY
PAT at Rs.116 cr vs Rs.50 cr,
up 2.3 Times YoY
DCW Limited has commissioned a Chlorinated Polyvinyl Chloride (CPVC) expansion project, increasing its production capacity by 10,000 MT at its Sahupuram Plant in Tamil Nadu.
The company plans to gradually ramp up production and commercialize the additional volumes. The total CPVC production capacity now stands at 20,000 MT.
The company plans to gradually ramp up production and commercialize the additional volumes. The total CPVC production capacity now stands at 20,000 MT.
Jehttps://www.bloomberg.com/news/articles/2023-10-30/jefferies-wood-says-india-stocks-may-fall-25-on-surprise-loss-of-modi-s-party#xj4y7vzkg
Jefferies Warns ⚠️ If BJP losses in 2024 stock mkts can see 25% Fall
What if BJP wins 🏆?
Answer is simple- Same % Of Upmove
Let's C
A
Jefferies Warns ⚠️ If BJP losses in 2024 stock mkts can see 25% Fall
What if BJP wins 🏆?
Answer is simple- Same % Of Upmove
Let's C
A
Wealthcreatures.com
LINCOLN PHARMA Only for Patience Holder Investment pick CMP - 240 ADD ON DIPS NEAR SUPPORT support @ 229/220 Promotors cont. Buying from open mkt. Good product line up TEST LEVELS # 300/400/500/600++ TF - 6/12/18/24 MONTHS S/L - 190 on closing…
Lincoln Pharma
Strong Set of Results for Q2
Fresh ATH 579 💚
Co. expects to achieve a Topline of Rs.750 crs. in FY26 (Current Topline FY23 is Rs.510 crs. & H1FY24 is Rs.308 crs.)
Co. has successfully completed expansion of the Cephalosporin plant at Mehsana, Gujarat. Commercial production from this plant has started. The plant is expected to contribute sales of around Rs. 150 crore in next 3 years
Won't be suprise to see 1000 + in next 2 years
Strong Set of Results for Q2
Fresh ATH 579 💚
Co. expects to achieve a Topline of Rs.750 crs. in FY26 (Current Topline FY23 is Rs.510 crs. & H1FY24 is Rs.308 crs.)
Co. has successfully completed expansion of the Cephalosporin plant at Mehsana, Gujarat. Commercial production from this plant has started. The plant is expected to contribute sales of around Rs. 150 crore in next 3 years
Won't be suprise to see 1000 + in next 2 years